Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-17

Clinical Trial Update: Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating hypofractionated radiotherapy for myxoid liposarcoma of extremities or trunk wall.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Myxoid Liposarcoma | Phase 2 | Status: UNKNOWN